MoCA is favored because it screens multiple cognitive domains that are often affected early, especially executive function, attention, and visuospatial skills, not just memory. This broader, more sensitive scope makes it better at catching mild cognitive impairment before symptoms become obvious. The test is designed with a relatively low ceiling, includes an optional education adjustment, and typically takes about 10 minutes to administer, which helps detect subtle changes that other tools miss. By contrast, the ABCD-2 is a stroke-risk assessment, not a cognitive measure. The MMSE is older and less sensitive to mild deficits, often missing early impairment. The GDS focuses on mood and depressive symptoms, which can mimic cognitive problems but doesn’t directly measure cognitive function. So MoCA’s combination of broad domain coverage and higher sensitivity explains why it’s the go-to for early cognitive decline.

In early dementia, reorientation is best supported by using cues from the environment and consistent routines. Signs, labels, and familiar environmental supports give external reference points that help a person recognize where they are, what time it is, and what comes next, without relying solely on memory. These cues tap into preserved abilities to respond to familiar, predictable contexts and reduce cognitive load, making navigation and daily activities feel more manageable. Verbal reassurance alone doesn’t provide lasting orientation because it depends on memory that’s already declining. Forcing someone to memorize long lists adds unnecessary strain and is unlikely to be effective. Avoiding cues removes helpful anchors and can increase confusion. With clear cues and steady routines, reorientation becomes smoother and supports smoother participation in daily life.

The role of the Speech-Language Pathologist in medication management is about understanding how medicines can affect communication and swallowing and working with the medical team to keep therapy safe and effective. SLPs do not prescribe medications; prescribing is the physician’s job. Instead, they educate patients and families about potential medication effects on speech, language, cognition, and swallowing, such as drowsiness, dry mouth, slowed swallow reflex, or voice changes that could impact therapy goals. They monitor for changes in swallowing safety or communication performance when a new medication is started or a dose changes, and they adapt therapy plans and strategies accordingly. They collaborate with doctors, pharmacists, and caregivers to coordinate care, ensuring that medication use supports, rather than hinders, communication and swallowing outcomes. If side effects interfere with safety or participation in therapy, the SLP can advocate for appropriate medical review, but the actual prescribing is done by the physician.

The main idea is that speech-language pathologists focus on communication and swallowing support in dementia care, not on medical diagnosis or prescribing medications. They play a key role in screening for changes in language, cognition affecting communication, and swallowing safety, then provide interventions to help the person communicate more effectively and safely swallow, along with training for caregivers and strategies to compensate for difficulties. They may offer cognitive-communication therapy and use aids or techniques like cueing, reminiscence-based strategies, or alternative communication methods to maximize functional communication as the dementia progresses. Diagnosing dementia and managing medications are medical tasks handled by physicians and other healthcare professionals, not SLPs. That’s why the statement that best fits is: SLPs can screen and provide interventions but cannot diagnose.